Form 4: Proto Labs Inc. Executive Oleg Ryaboy Reports Stock Transactions
SEC Form 4 Filing
Chief Technology Officer Oleg Ryaboy reports acquisition of common stock and stock options in Proto Labs Inc.
Summary
- Oleg Ryaboy, Chief Technology Officer of Proto Labs Inc., filed a Form 4 detailing changes in beneficial ownership.
- On February 25, 2025, Ryaboy acquired 7,574 shares of common stock and 6,798 employee stock options.
- The common stock was acquired at $0, and the exercise price of the stock options is $39.61.
- These options become exercisable starting February 25, 2026, with 25% vesting each year until fully vested, and expire on February 25, 2035.
- Following these transactions, Ryaboy directly owns 35,305 shares of common stock and 6,798 derivative securities.
Sentiment
Score: 5
Explanation: Neutral sentiment as it is a standard disclosure of stock transactions by an executive. The acquisition of shares and options could be seen as a mildly positive signal, but it's not definitive.
Positives
- The acquisition of stock and options by a key executive could be interpreted as a positive signal about the executive's confidence in the company's future prospects.
Future Outlook
The document does not contain explicit forward-looking statements, but the vesting schedule of the stock options suggests a multi-year commitment from the executive.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's valuation and future prospects.
Comparison to Industry Standards
- Stock option grants and vesting schedules are common compensation practices in the technology industry.
- The vesting schedule of 25% per year is a fairly standard arrangement.
- Comparing the size of the grant to those of executives at similar companies (e.g., Stratasys, 3D Systems) would provide further context.
Stakeholder Impact
- Shareholders may view the executive's stock acquisition as a positive sign of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 02/25/2025 | Date of transaction: acquisition of common stock and stock options. |
| 02/25/2026 | First vesting date for 25% of the acquired stock options. |
| 02/27/2025 | Date of Form 4 filing. |
| 02/25/2035 | Expiration date of the acquired stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.